These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25866450)

  • 1. Roles of lymphocyte kv1.3-channels in the pathogenesis of renal diseases and novel therapeutic implications of targeting the channels.
    Kazama I
    Mediators Inflamm; 2015; 2015():436572. PubMed ID: 25866450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases.
    Kazama I; Tamada T; Tachi M
    Inflamm Res; 2015 Oct; 64(10):753-65. PubMed ID: 26206235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease.
    Kazama I
    J Physiol Sci; 2015 Jan; 65(1):25-35. PubMed ID: 25096892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benidipine persistently inhibits delayed rectifier K(+)-channel currents in murine thymocytes.
    Kazama I; Maruyama Y; Matsubara M
    Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):28-33. PubMed ID: 22978806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benidipine suppresses in situ proliferation of leukocytes and slows the progression of renal fibrosis in rat kidneys with advanced chronic renal failure.
    Kazama I; Baba A; Matsubara M; Endo Y; Toyama H; Ejima Y
    Nephron Exp Nephrol; 2014; 128(1-2):67-79. PubMed ID: 25358915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed Rectifier K
    Abe N; Toyama H; Saito K; Ejima Y; Yamauchi M; Mushiake H; Kazama I
    Biomed Res Int; 2019; 2019():7567638. PubMed ID: 31828127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of lymphocyte Kv1.3-channels in gut mucosal immune system: Novel therapeutic implications for inflammatory bowel disease.
    Kazama I
    Med Hypotheses; 2015 Jul; 85(1):61-3. PubMed ID: 25847395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockage of K(Ca)3.1 and Kv1.3 channels of the B lymphocyte decreases the inflammatory monocyte chemotaxis.
    Zhang S; Wang X; Ju C; Zhu L; Du Y; Gao C
    Int Immunopharmacol; 2016 Feb; 31():266-71. PubMed ID: 26795234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte Kv1.3-channels in the pathogenesis of chronic obstructive pulmonary disease: novel therapeutic implications of targeting the channels by commonly used drugs.
    Kazama I; Tamada T
    Allergy Asthma Clin Immunol; 2016; 12():60. PubMed ID: 27956907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in the neonate.
    Toldi G; Treszl A; Pongor V; Gyarmati B; Tulassay T; Vásárhelyi B
    Int Immunol; 2010 Sep; 22(9):769-74. PubMed ID: 20601376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
    Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis.
    Toldi G; Bajnok A; Dobi D; Kaposi A; Kovács L; Vásárhelyi B; Balog A
    Immunobiology; 2013 Mar; 218(3):311-6. PubMed ID: 22705192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different calcium influx characteristics upon Kv1.3 and IKCa1 potassium channel inhibition in T helper subsets.
    Orbán C; Bajnok A; Vásárhelyi B; Tulassay T; Toldi G
    Cytometry A; 2014 Jul; 85(7):636-41. PubMed ID: 24827427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases.
    Beeton C; Pennington MW; Wulff H; Singh S; Nugent D; Crossley G; Khaytin I; Calabresi PA; Chen CY; Gutman GA; Chandy KG
    Mol Pharmacol; 2005 Apr; 67(4):1369-81. PubMed ID: 15665253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte activation in type 1 diabetes mellitus: the increased significance of Kv1.3 potassium channels.
    Toldi G; Vásárhelyi B; Kaposi A; Mészáros G; Pánczél P; Hosszufalusi N; Tulassay T; Treszl A
    Immunol Lett; 2010 Sep; 133(1):35-41. PubMed ID: 20603149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18β-Glycyrrhetinic acid potently inhibits Kv1.3 potassium channels and T cell activation in human Jurkat T cells.
    Fu XX; Du LL; Zhao N; Dong Q; Liao YH; Du YM
    J Ethnopharmacol; 2013 Jul; 148(2):647-54. PubMed ID: 23707333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressing leukocyte Kv1.3-channels by commonly used drugs: A novel therapeutic target for schizophrenia?
    Sato Y; Kuwana R; Kazama I
    Drug Discov Ther; 2022 May; 16(2):93-95. PubMed ID: 35444072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological role of Kv1.3 channel in T lymphocyte cell investigated quantitatively by kinetic modeling.
    Hou P; Zhang R; Liu Y; Feng J; Wang W; Wu Y; Ding J
    PLoS One; 2014; 9(3):e89975. PubMed ID: 24594979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acacetin blocks kv1.3 channels and inhibits human T cell activation.
    Zhao N; Dong Q; Fu XX; Du LL; Cheng X; Du YM; Liao YH
    Cell Physiol Biochem; 2014; 34(4):1359-72. PubMed ID: 25301362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.